EF Hutton Maintains Buy on iSpecimen, Lowers Price Target to $4.25

EF Hutton analyst Constantine Davides maintains iSpecimen (NASDAQ:ISPC) with a Buy and lowers the price target from $5.5 to $4.25.

EF Hutton analyst Constantine Davides maintains iSpecimen (NASDAQ:ISPC) with a Buy and lowers the price target from $5.5 to $4.25.

Total
0
Shares
Related Posts